Early clinical data of Intralink-Spine's Réjuve System for low back pain is positive: 5 observations

Megan Wood -   Print  |

Kuala Lumpur, Malaysia-based Pantai Medical Center researchers have gathered early clinical study data on Lexington, Ky.-based Intralink-Spine's Réjuve System.

Here are five observations:


1. Orthopedic surgeon Dr. Harwant Singh utilized the Réjuve System for four procedures.


2. The procedures involved fluoroscopic image-guided injections of the Réjuve medical device in the lumbar intervertebral discs.


3. The data points to an average decrease of 93 percent in Visual Analog Scale pain scores at two weeks post-operation compared to pre-operation.


4. Oswestry Disability Index scores decreased 84 percent on average.


5. Intralink-Spine hopes one or two sets of injections of the Réjuve medical device will permanently relieve low back pain.


"These initial data support our belief that this device can be safely and effectively delivered to the affected disc using our protocol and standard fluoroscopic techniques," said Tom Hedmen, PhD, chief scientific officer, Intralink-Spine.


More articles on devices:
FDA's updated draft guidance provides insight into device modification applications: 5 insights
3 quick points on Xtant Medical's financial state
Room for one more? Drs. Dennis Devito & Kornelis Poelstra on using Mazor Robotics technology during spine surgeries

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers